- Home
- DHC vs KROS Comparison
DHC vs KROS Comparison
Compare DHC & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHC
- KROS
- Stock Information
- Founded
- DHC 1998
- KROS 2015
- Country
- DHC United States
- KROS United States
- Employees
- DHC N/A
- KROS N/A
- Industry
- DHC Real Estate Investment Trusts
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- DHC Real Estate
- KROS Health Care
- Exchange
- DHC Nasdaq
- KROS Nasdaq
- Market Cap
- DHC 629.7M
- KROS 589.8M
- IPO Year
- DHC N/A
- KROS 2020
- Fundamental
- Price
- DHC $2.05
- KROS $10.86
- Analyst Decision
- DHC Hold
- KROS Buy
- Analyst Count
- DHC 3
- KROS 11
- Target Price
- DHC $4.50
- KROS $45.33
- AVG Volume (30 Days)
- DHC 1.1M
- KROS 1.9M
- Earning Date
- DHC 02-24-2025
- KROS 02-26-2025
- Dividend Yield
- DHC 1.94%
- KROS N/A
- EPS Growth
- DHC N/A
- KROS N/A
- EPS
- DHC N/A
- KROS N/A
- Revenue
- DHC $1,477,343,000.00
- KROS $651,000.00
- Revenue This Year
- DHC N/A
- KROS $303.39
- Revenue Next Year
- DHC $4.46
- KROS N/A
- P/E Ratio
- DHC N/A
- KROS N/A
- Revenue Growth
- DHC 6.62
- KROS 8037.50
- 52 Week Low
- DHC $2.01
- KROS $9.78
- 52 Week High
- DHC $4.24
- KROS $73.00
- Technical
- Relative Strength Index (RSI)
- DHC 29.32
- KROS 20.25
- Support Level
- DHC $2.02
- KROS $9.78
- Resistance Level
- DHC $2.17
- KROS $16.49
- Average True Range (ATR)
- DHC 0.09
- KROS 0.92
- MACD
- DHC 0.00
- KROS 0.97
- Stochastic Oscillator
- DHC 10.81
- KROS 14.52
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.